Inflammation markers in point-of-care testing (POCT)

被引:161
作者
Pfaefflin, Albrecht [1 ]
Schleicher, Erwin [1 ]
机构
[1] Univ Tubingen Hosp, Dept Internal Med 4, Clin Chem Unit, D-72076 Tubingen, Germany
关键词
Point-of-care testing; Inflammation; Infection; Sepsis; CRP; Procalcitonin; Leukocyte; Granulocyte; Interleukin cost-efficiency; Clinical outcome; C-REACTIVE PROTEIN; COMMUNITY-ACQUIRED PNEUMONIA; DIAGNOSTIC MARKER; RESPONSE SYNDROME; SEVERE SEPSIS; PROCALCITONIN; EXPRESSION; INTERLEUKIN-6; IMMUNOASSAY; INFECTION;
D O I
10.1007/s00216-008-2561-3
中图分类号
Q5 [生物化学];
学科分类号
070307 [化学生物学];
摘要
Inflammation is a central issue in medicine. Inflammatory processes may be local or systemic, acute or chronic, and they may be benign or fatal. In bacterial or viral infections fast and reliable diagnosis is essential for appropriate treatment, e.g. antimicrobial therapy. The time to diagnosis is critical because uncontrolled infections may lead to sepsis with a mortality rate close to 50%. Beside clinical signs, laboratory markers are important in detecting, differentiating, and monitoring inflammation, particularly acute infections. Currently several inflammation markers including leukocyte count and leukocyte differentiation, C-reactive protein (CRP), procalcitonin (PCT), and interleukins (IL) 6 and 8, is available, and potential future serum markers are under development. In this article the clinical use of these markers in routine laboratory and in point-of-care testing is described and the diagnostic value of the four groups of laboratory marker is compared. Current data show that leukocyte count or, better, neutrophil count, CRP, and PCT are well suited to support of rapid diagnosis of inflammation and infections in children and adults whereas measurement of IL-6 and 8 are preferable for detection of sepsis in neonates.
引用
收藏
页码:1473 / 1480
页数:8
相关论文
共 52 条
[1]
Transactivation of c-reactive protein by IL-6 requires synergistic interaction of CCAAT/enhancer finding protein β (C/EBPβ) and Rel p50 [J].
Agrawal, A ;
Cha-Molstad, H ;
Samols, D ;
Kushner, I .
JOURNAL OF IMMUNOLOGY, 2001, 166 (04) :2378-2384
[2]
Aikawa Naoki, 2005, Journal of Infection and Chemotherapy, V11, P152, DOI 10.1007/s10156-005-0388-9
[3]
Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care [J].
Angus, DC ;
Linde-Zwirble, WT ;
Lidicker, J ;
Clermont, G ;
Carcillo, J ;
Pinsky, MR .
CRITICAL CARE MEDICINE, 2001, 29 (07) :1303-1310
[4]
Community-acquired bacterial meningitis: Risk stratification for adverse clinical outcome and effect of antibiotic timing [J].
Aronin, SI ;
Peduzzi, P ;
Quagliarello, VJ .
ANNALS OF INTERNAL MEDICINE, 1998, 129 (11) :862-869
[5]
Evaluation of faecal occult blood test and lactoferrin latex agglutination test in screening hospitalized patients for diagnosing inflammatory and non-inflammatory diarrhoea in Dhaka, Bangladesh [J].
Ashraf, Hasan ;
Beltinger, Johannes ;
Alam, Nur Haque ;
Bardhan, Pradip Kumar ;
Faruque, Abu Syed Golam ;
Akter, Jesmin ;
Salam, Mohammed Abdus ;
Gyr, Niklaus .
DIGESTION, 2007, 76 (3-4) :256-261
[6]
Microfluidic immunosensor systems [J].
Bange, A ;
Halsall, HB ;
Heineman, WR .
BIOSENSORS & BIOELECTRONICS, 2005, 20 (12) :2488-2503
[7]
Pyocalcitonin assay in systemic inflammation, infection, and sepsis: Clinical utility and limitations [J].
Becker, Kenneth L. ;
Snider, Richard ;
Nylen, Eric S. .
CRITICAL CARE MEDICINE, 2008, 36 (03) :941-952
[8]
C-reactive protein [J].
Black, S ;
Kushner, I ;
Samols, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (47) :48487-48490
[9]
Improving management of patients with acute cough by C-reactive protein point of care testing and communication training (IMPAC3T):: study protocol of a cluster randomised controlled trial [J].
Cals, Jochen W. L. ;
Hopstaken, Rogier M. ;
Butler, Christopher C. ;
Hood, Kerenza ;
Severens, Johan L. ;
Dinant, Geert-Jan .
BMC FAMILY PRACTICE, 2007, 8 (1)
[10]
Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction [J].
Castelli, GP ;
Pognani, C ;
Meisner, M ;
Stuani, A ;
Bellomi, D ;
Sgarbi, L .
CRITICAL CARE, 2004, 8 (04) :R234-R242